Ara
Toplam kayıt 1, listelenen: 1-1
Retrospective Evaluation of Patients Treated with Dasatinib For Philadelphia Positive Leukemias: Turkish Experience of 16 Months
(Akad Doktorlar Yayınevi, 2009)
This retrospective study was conducted on 114 CML patients with a mean treatment duration of 7.94 +/- 4.53 months. Disease status distribution among patients was 78.1% in chronic, 7.9% in accelerated, 14% in blastic phases. ...